Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invivo Partners is a leading Spanish venture capital firm specializing in early-stage investments across the life sciences sector. They focus on advanced therapies, synthetic biology, and artificial intelligence applications within healthcare. The firm has managed three funds to date and has invested in over 15 portfolio companies with several notable exits such as Sanifit and Versantis. Recent investments include participation in significant funding rounds for Arthex (€42M Series B) and Corteria (€65M Series A), reflecting their commitment to transformative science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invivo Partners.